Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) saw a significant increase in short interest in September. As of September 30th, there was short interest totaling 454 shares. Based on an average daily volume of 422 shares, the days-to-cover ratio is presently 1.1 days.
Hikma Pharmaceuticals Stock Performance
Shares of HKMPY stock traded up $2.37 on Thursday, hitting $44.40. The stock had a trading volume of 272 shares, compared to its average volume of 1,245. The business has a 50 day moving average price of $43.28 and a 200 day moving average price of $40.70. Hikma Pharmaceuticals has a one year low of $31.80 and a one year high of $49.31.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC is a global pharmaceutical company headquartered in London, United Kingdom. Founded in 1978 by Samih Darwazah in Jordan, the company develops, manufactures and markets a broad range of prescription medicines for healthcare providers and patients.
Hikma operates through three principal businesses: Injectables, Generics and Branded Medicines. Its portfolio includes hospital injectable products, specialty and generic medicines, and branded pharmaceutical products in areas such as respiratory care, cardiovascular treatment, pain management, anti-infectives and central nervous system therapies.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
